Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06572085
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-25
Brief Title:
Neuroprotective Effect of Butylphthalide for Cardiac Arrest Patients
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Neuroprotective Effect of Butylphthalide Injection on Patients With Return of Spontaneous Circulation After Cardiac Arresta Multicenter Randomized Clinical Trial
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Cardiac arrest is one of the critical illnesses that is directly life-threatening and patients who survive cardiac arrest develop severe neurological deficits or even die The effectiveness of drugs to improve neurological function in resuscitated brain-injured patients has been a focus of research in the field of resuscitation Butanephthalein has an ameliorating effect on the damage of central nervous function in patients with acute ischemic stroke and can promote the improvement of patients neurological deficits On this basis the present study was designed as a multicenter prospective randomized controlled experiment with internationally accepted methods for assessing near-term and long-term neurological function to determine the effectiveness of butalbital in improving neurological function after cardiac arrest with the aim of searching for new methods and ideas to improve neurological function and prognosis after cardiac arrest
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None